Brachytherapy Devices Market size is valued at USD 792.2 million in 2021 and is expected to grow at a CAGR of 7.4% during the forecast period 2022 to 2028. The global market provides a detailed overview of the Brachytherapy Devices market and which can be segmented by type, application, end-user, and region. By type, the Brachytherapy Devices market has been segmented into high dose rate brachytherapy and low dose rate brachytherapy. By type, the high dose rate brachytherapy segment dominated the market and accounted for the largest revenue share in past years. The high dose rate therapy is generally done as an outpatient procedure for the treatment of various types of cancers such as skin, cervical, prostate, head, neck, and breast cancer within a short procedure time, higher efficacy, and protection from radiation exposure. By application, the Brachytherapy Devices market has been segmented into gynecological cancer, prostate cancer, skin cancer, breast cancer, cervical cancer, and others. By application, the breast cancer segment is expected to witness the highest CAGR during the forecast period owing to the increasing usage of brachytherapy in accelerated partial breast irradiation (APBI). Furthermore, the rising incidence of breast cancer is also expected to propel the growth of this segment. Based on the end user, the segment has been segregated into hospitals, diagnostic centers, ambulatory surgical centers, and radiotherapy centers. The radiotherapy centers segment is expected to lead the end-user segments owing to continuous development in cancer treatment devices by numerous radiotherapy centers across developed countries.
In July 2021, Genesis Care extends U.S. brachytherapy service with 27 Elekta Flexitron treatment devices.